Which one of the following is not a clinical use of spironolactone ?
**Core Concept**
Spironolactone is a potassium-sparing diuretic that acts as a competitive antagonist of aldosterone at the mineralocorticoid receptor, primarily in the collecting duct of the kidneys. This mechanism enables it to promote sodium excretion and water retention, while sparing potassium ions.
**Why the Correct Answer is Right**
Spironolactone's use in clinical practice is multifaceted, primarily due to its mineralocorticoid receptor antagonism. It is employed in the management of conditions such as heart failure, where it helps reduce morbidity and mortality by alleviating fluid overload. Additionally, spironolactone is effective in treating primary aldosteronism, a condition characterized by excessive aldosterone production, thereby mitigating the associated hypertension and hypokalemia. Furthermore, its anti-androgenic properties make it a viable treatment option for hirsutism in women with polycystic ovary syndrome (PCOS).
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because spironolactone is indeed used as a treatment for primary aldosteronism, a condition characterized by excessive aldosterone production.
**Option B:** Incorrect because spironolactone is used in the management of heart failure, where it helps reduce morbidity and mortality by alleviating fluid overload.
**Option C:** Incorrect because spironolactone has anti-androgenic properties, making it a viable treatment option for hirsutism in women with PCOS.
**Clinical Pearl / High-Yield Fact**
A key consideration when prescribing spironolactone is its potential to cause hyperkalemia, particularly in patients with renal impairment or those taking other potassium-sparing diuretics. Regular monitoring of potassium levels is essential to prevent this complication.
**Correct Answer:** D